Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation

Jeana D. O'Brien, James H. Lium, James F. Parosa, Barry R. Deyoung, Mark R. Wick, Elbert P. Trulock

Research output: Contribution to journalArticlepeer-review

85 Scopus citations


The evolution of lung transplantation has offered an additional treatment option for patients with a variety of end-stage lung diseases, including some with systemic disorders. Lymphangiomyomatosis (LAM) is a multisystem disease of premenopausal women. The lung is the most frequently involved vital organ, and respiratory failure is the most common case of death. A small number of patients with LAM have undergone lung transplantation. This report describes a case of recurrent LAM in the allograft after single lung transplantation and discusses the implications of this finding.

Original languageEnglish
Pages (from-to)2033-2036
Number of pages4
JournalAmerican journal of respiratory and critical care medicine
Issue number6
StatePublished - Jun 1995


Dive into the research topics of 'Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation'. Together they form a unique fingerprint.

Cite this